tirzepatide type 1 diabetes trial monotherapy in Chinese patients with early 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) Tirzepatide Shows Superior Weight Loss
Pay in 4 interest-free payments of $7.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
























